Effects of multidrug resistance (MDR1) P-glycoprotein expression levels and coordination metal on the cytotoxic potency of multidentate (N4O2) (ethylenediamine)bis[propyl(R-benzylimino)]metal(III) cations

Journal of Medicinal Chemistry

Volumn 39, Issue 18, 1996, Pages 3483-3490

  Sharma, Vijay ^a   Crankshaw, Carolyn L ^a   Piwnica Worms, David ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; ANTINEOPLASTIC AGENT; CATION; ETHYLENEDIAMINE DERIVATIVE; GALLIUM; GLYCOPROTEIN P; INDIUM; IRON; LIGAND; METAL DERIVATIVE;

ARTICLE; CYTOTOXICITY; DRUG ACTIVITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; HUMANS; ORGANOMETALLIC COMPOUNDS; P-GLYCOPROTEIN;

EID: 0029844272     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm950823c     Document Type: Article

References (49)

1. Lichtshtein, D.; Kaback, H. R.; Blume, A. J. Use of a lipophilic cation for determination of membrane potential in neuroblastoma-glioma hybrid cell suspensions. Proc. Natl. Acad. Sci. U.S.A., 1979, 76, 650-654.
2. Johnson, L.; Walsh, M.; Chen, L. Localization of mitochondria in living cells with rhodamine 123. Proc. Natl. Acad. Sci. U.S.A., 1980, 77, 990-994.
3. Davis, S.; Weiss, M.; Wong, J.; Lampidis, T.; Chen, L. Mitochondrial and plasma-membrane potentials cause unusual accumulation and retention of rhodamine-123 by human breast adenocarcinoma-derived MCF-7 cells. J. Biol. Chem. 1985, 260, 13844-13850.
4. Langston, J. W.; Ballard, P.; Tetrud, J. W.; Irwin, I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983, 219, 979-980.
5. +. Biochem. Biophys. Res. Commun. 1986, 134, 743-748.
6. Piwnica-Worms, D.; Kronauge, J. F.; Chiu, M. L. Uptake and retention of hexakis (2-methoxy isobutyl isonitrile) technetium(I) in cultured chick myocardial cells: mitochondrial and plasma membrane potential dependence. Circulation 1990, 82, 1826-1838.
7. Backus, M.; Piwnica-Worms, D.; Hockett, D.; Kronauge, J.; Lieberman, M.; Ingram, P.; LeFurgey, A. Microprobe analysis of Tc-MIBI in heart cells: calculation of mitochondrial potential. Am. J. Physiol: Cell 1993, 265, C178-C187.
8. Crane, P.; Laliberte, R.; Heminway, S.; Thoolen, M.; Orlandi, C. Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention. Eur. J. Nucl. Med. 1993, 20, 20-25.
9. Piwnica-Worms, D.; Kronuage, J. F.; LeFurgey, A.; Backus, M.; Hockett, D.; Ingram, P.; Lieberman, M.; Holman, B. L.; Jones, A. G.; Davison, A. Mitochondrial localization and characterization of 99-Tc-SESTAMIBI in heart cells by electron probe X-ray microanalysis and 99-Tc-NMR spectroscopy. Magn. Reson. Imaging 1994, 12, 641-652.
10. Ritchie, R. J. A critical assessment of the use of lipophilic cations as membrane potential probes. Prog. Biophys. Mol. Biol. 1984, 43, 1-32.
11. Chernoff, D. M.; Strichartz, G. R.; Piwnica-Worms, D. Membrane potential determination in large unilamellar vesicles with hexakis(2-methoxyisobutyl isonitrile)technetium(I). Biochim. Biophys. Acta 1993, 1147, 262-266.
12. Gluck, M.; Krueger, M.; Ramsay, R.; Sablin, S.; Singer, T.; Nicklas, W. Characterization of the inhibitory mechanism of 1-methyl-4-phenylpyridinium and 4-phenylpyridine analogs in inner membrane preparations. J. Biol. Chem. 1994, 269, 3167-3174.
13. Wackers, F. J.; Berman, D.; Maddahi, J.; Beller, G.; Straus, H.; Boucher, C.; Picard, M.; Holman, B.; Fridrich, R. Tc-99m-hexakis 2-methoxy isobutlisonitrile:human biodistribution, dosimetry, safety and preliminary comparison to thallium-201 for myocardial perfusion imaging. J. Nucl. Med. 1989, 30, 301-309.
14. Chen, L. B. Mitochondrial membrane potential in living cells. Annu. Rev. Cell Biol. 1988, 4, 155-181.
15. Koya, K.; Li, Y.; Wang, H.; Ukai, T.; Tatsuta, N.; Kawakami, M.; Shishido, T.; Chen, L. MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation. Cancer Res. 1996, 56, 538-543.
16. Piwnica-Worms, D.; Chiu, M. L.; Budding, M.; Kronauge, J. F.; Kramer, R. A.; Croop, J. M. Functional imaging of multidrugresistant P-glycoprotein with an organotechnetium complex. Cancer Res. 1993, 53, 1-8.
17. Bryce-Smith, D. Environmental chemical influences on behaviour and mentation. Chem. Soc. Rev. 1986, 15, 93-123.
18. May, P. M.; Bulman, R. A. The present status of chelating agents in medicine. Prog. Med. Chem. 1983, 20, 225-336.
19. Deutsch, E.; Libson, K.; Jurisson, K.; Lindoy, L. F. Technetium chemistry and technetium radiopharmaceuticals. Prog. Inorg. Chem. 1983, 30, 75-139.
20. Lauffer, R. Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem. Rev. 1987, 87, 901-927.
21. Kumar, K.; Tweedle, M. F. Macrocyclic polyaminocarboxylate complexes of lanthanides as magnetic resonance imaging contrast agents. Pure Appl. Chem. 1993, 65, 515.
22. Xu, J.; Franklin, S. J.; Whisenhunt, D. W.; Raymond, K. N. Gadolinium complex of tris[(3-hydroxy-1-methyl-2-oxo-1,2-didehydropyridine-4-carboxamido)ethyl]-amine: a new class of gadolinium magnetic resonance relaxation agents. J. Am. Chem. Soc. 1995, 117, 7245-7246.
23. Abrams, M.; Murrer, B. Metal compounds in therapy and diagnosis. Science 1993, 261, 725-730.
24. Palucki, M.; McCormick, G. J.; Jacobsen, E. N. Low temperature assymmetric epoxidation of unfunctionalzed olefins catalyzed by (salen)Mn(III) complexes. Tetrahedron Lett. 1995, 36, 5457-5460.
25. Isobe, T.; Kida, S.; Misumi, S. Preparation of schiff base complexes of lanthanides(III) ions. Bull. Chem. Soc. Jpn. 1967, 40, 1862-1863.
26. 3trien'. Inorg. Chim. Acta 1977, 25, L137-138.
27. Evans, D. F.; Jakubovic, D. A. Water soluble hexadentate schiffbase ligands as sequestrating agents for iron(III) and gallium(III). J. Chem. Soc. Dalton Trans. 1988, 2927-2933.
28. Sarma, B. D.; Bailar, J. C. The stereochemistry of metal complexes with polydentate ligands. Part I. J . Am. Chem. Soc. 1955, 77, 5476-5480.
29. Sarma, B. D.; Ray, K. R.; Sievers, R. E.; Bailar, J. C. The stereochemistry of metal chelates with multidentate ligands. Part II. J. Am. Chem. Soc. 1964, 86, 14-16.
30. Tweedle, M. F.; Wilson, L. J. Variable spin iron(III) chelates with hexadentate ligands derived from triethylenetetramine and various salicyaldehydes. J. Am. Chem. Soc. 1976, 98, 4824-4834.
31. 2 amine phenol complexes of gallium and indium. Inorg. Chem. 1995, 34, 93-101.
32. 3 Schiff base and amine phenol ligands of variable rigidity. Inorg. Chem. 1995, 34, 2164-2178.
33. n polymer with profuse modes of nitrate coordination. Inorg. Chem. 1995, 34, 4921-4925.
34. Green, M. A.; Welch, M. J.; Huffman, J. C. Synthesis and crystallographic characterization of a gallium salicylaldimine complex of radiopharmaceutical interest. J. Am. Chem. Soc. 1984, 106, 3689-3691.
35. +. J. Nucl. Med. 1993, 34, 1127-1131.
36. Tsang, B. W,; Mathias, C. J.; Fanwick, P. E.; Green, M. A. Structure-distribution relationship for metal-labelled myocardial imaging agents: Comparison of a series of cationic gallium(III) complexes with hexadentate bis(salicylaldimine) ligands. J. Med. Chem. 1994, 37, 4400-4406.
37. Shannon, R. D. Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenides. Acta Crystallogr. 1976, A32, 751-767.
38. Geary, W. J. The use of conductivity measurements in organic solvents for the characterization of coordination compounds. Coord. Chem. Rev. 1971, 7, 81-122.
39. 2 spheres incorporating hexadentate amideamine-phenolate coordination. Inorg. Chem. 1992, 31, 760-765.
40. Ito, T.; Sugimoto, M.; Ito, H.; Toriumi, K.; Nakayama, H.; Mori, W.; Sekizaki, M. A chelate ring size effect on spin states of iron(III) complexes with hexadentate ligands derived from salicylaldehyde and 4,8-diazaundecane-1,11-diamine (3,3,3-tet) or 4,7-diazadecane-1,10-diamine (3,2,3-tet) and their X-ray structures. Chem. Lett. 1983, 121-124.
41. Sharma, V.; Reichert, D.; Crankshaw, C.; Welch, M. J.; Piwnica-Worms, D. Effects of the central coordination metal on recognition of ethylenediamine-N,N′-bis(propyl(R-benzylimino)]metal(III) cations by multidrug resistance (MDR1) p-glycoprotein. J. Nucl. Med. 1996, 37, 71P.
42. Gros, P.; Ben Neriah, Y.; Croop, J. M.; Housman, D. E. Isolation and expression of a complementary DNA that confers multidrug resistance. Nature 1986, 323, 728-731.
43. Shen, D. W.; Fojo, A.; Chin, J. E.; Roninson, I. B.; Richert, N.; Pastan, I.; Gottesman, M. M. Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification. Science 1986, 232, 643-645.
44. Gottesman, M. M.; Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 1993, 62, 385-427.
45. Ford, J. M.; Hait, W. N. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev. 1990, 42, 155-199.
46. Akiyama, S. I.; Fojo, A.; Hanover, J. A.; Pastan, I.; Gottesman, M. M. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somatic Cell. Mol. Genet. 1985, 11, 117-126.
47. Dolci, E. D.; Abramson, R.; Xuan, Y.; Siegfried, J.; Yuenger, K. A.; Yassa, D. S.; Tritton, T. R. Anomalous expression of P-glycoprotein in highly drug-resistant human KB cells. Int. J. Cancer 1993, 54, 302-308.
48. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J. T.; Bokesch, H.; Kenney, S.; Boyd, M. R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 1990, 82, 1107-1112.
49. Glantz, S. A. Primer of Biostatistics, 2nd ed.; Mcgraw-Hill, Inc.: New York, 1987; p 379.